This paper describes the design, development, and implementation of a ubiquitous portfolio (u-portfolio) system aimed at enhancing clinical clerkship education at Inje University College of Medicine from 2016 to 2020. This developmental research employed involved a literature review of 69 papers on electronic portfolios (1990–2013), and as well as a series of focus group interviews and surveys with key stakeholders during the iterative design, evaluation, and revision process. The literature analysis revealed three main purposes of e-portfolios (learning, assessment, and showcase) and nine key elements for a multi-purpose e-portfolio (e.g., quality of student reflection, postgraduate continuous learning, and timely and frequent feedback). The system evolved from paper-based portfolios to address the standardization of students’ clerkship experiences across five teaching hospitals, incorporating competency-based education and enabling efficient data management to promote student learning, assessment, and feedback. Key challenges in transitioning from paper to electronic portfolios included infrastructure issues, user adaptation, and assessment standardization. The resulting u-portfolio system, which allowed the seamless integration of mobile devices, emphasized five core functions: enhanced real-time feedback, transparent evaluation with rubrics, improved reflection quality, real-time assessment and tracking, and mapping between learning and competency achievements. Initially implemented in the internal medicine clerkship in 2016, the system was gradually expanded to all core clerkships by 2018. The success of this system led to its adoption by 19 medical schools through a consortium organized by the Korea Association of Medical Colleges, with 31 schools now collaborating to enhance clerkships through the u-portfolio system.

This paper describes the design, development, and implementation of a ubiquitous portfolio (u-portfolio) system aimed at enhancing clinical clerkship education at Inje University College of Medicine from 2016 to 2020. This developmental research employed involved a literature review of 69 papers on electronic portfolios (1990–2013), and as well as a series of focus group interviews and surveys with key stakeholders during the iterative design, evaluation, and revision process. The literature analysis revealed three main purposes of e-portfolios (learning, assessment, and showcase) and nine key elements for a multi-purpose e-portfolio (e.g., quality of student reflection, postgraduate continuous learning, and timely and frequent feedback). The system evolved from paper-based portfolios to address the standardization of students’ clerkship experiences across five teaching hospitals, incorporating competency-based education and enabling efficient data management to promote student learning, assessment, and feedback. Key challenges in transitioning from paper to electronic portfolios included infrastructure issues, user adaptation, and assessment standardization. The resulting u-portfolio system, which allowed the seamless integration of mobile devices, emphasized five core functions: enhanced real-time feedback, transparent evaluation with rubrics, improved reflection quality, real-time assessment and tracking, and mapping between learning and competency achievements. Initially implemented in the internal medicine clerkship in 2016, the system was gradually expanded to all core clerkships by 2018. The success of this system led to its adoption by 19 medical schools through a consortium organized by the Korea Association of Medical Colleges, with 31 schools now collaborating to enhance clerkships through the u-portfolio system.

Purpose: Considering the high disease burden and unique features of Asian patients with breast cancer (BC), it is essential to have a comprehensive view of genetic characteristics in this population. An institutional targeted sequencing platform was developed through the Korea Research-Driven Hospitals project and was incorporated into clinical practice. This study explores the use of targeted next-generation sequencing (NGS) and its outcomes in patients with advanced/metastatic BC in the real world. Materials and Methods: We reviewed the results of NGS tests administered to BC patients using a customized sequencing platform—FiRST Cancer Panel (FCP)—over 7 years. We systematically described clinical translation of FCP for precise diagnostics, personalized therapeutic strategies, and unraveling disease pathogenesis. Results: NGS tests were conducted on 548 samples from 522 patients with BC. Ninety-seven point six percentage of tested samples harbored at least one pathogenic alteration. The common alterations included mutations in TP53 (56.2%), PIK3CA (31.2%), GATA3 (13.8%), BRCA2 (10.2%), and amplifications of CCND1 (10.8%), FGF19 (10.0%), and ERBB2 (9.5%). NGS analysis of ERBB2 amplification correlated well with human epidermal growth factor receptor 2 immunohistochemistry and in situ hybridization. RNA panel analyses found potentially actionable and prognostic fusion genes. FCP effectively screened for potentially germline pathogenic/likely pathogenic mutation. Ten point three percent of BC patients received matched therapy guided by NGS, resulting in a significant overall survival advantage (p=0.022), especially for metastatic BCs. Conclusion Clinical NGS provided multifaceted benefits, deepening our understanding of the disease, improving diagnostic precision, and paving the way for targeted therapies. The concrete advantages of FCP highlight the importance of multi-gene testing for BC, especially for metastatic conditions.

This paper describes the design, development, and implementation of a ubiquitous portfolio (u-portfolio) system aimed at enhancing clinical clerkship education at Inje University College of Medicine from 2016 to 2020. This developmental research employed involved a literature review of 69 papers on electronic portfolios (1990–2013), and as well as a series of focus group interviews and surveys with key stakeholders during the iterative design, evaluation, and revision process. The literature analysis revealed three main purposes of e-portfolios (learning, assessment, and showcase) and nine key elements for a multi-purpose e-portfolio (e.g., quality of student reflection, postgraduate continuous learning, and timely and frequent feedback). The system evolved from paper-based portfolios to address the standardization of students’ clerkship experiences across five teaching hospitals, incorporating competency-based education and enabling efficient data management to promote student learning, assessment, and feedback. Key challenges in transitioning from paper to electronic portfolios included infrastructure issues, user adaptation, and assessment standardization. The resulting u-portfolio system, which allowed the seamless integration of mobile devices, emphasized five core functions: enhanced real-time feedback, transparent evaluation with rubrics, improved reflection quality, real-time assessment and tracking, and mapping between learning and competency achievements. Initially implemented in the internal medicine clerkship in 2016, the system was gradually expanded to all core clerkships by 2018. The success of this system led to its adoption by 19 medical schools through a consortium organized by the Korea Association of Medical Colleges, with 31 schools now collaborating to enhance clerkships through the u-portfolio system.

Purpose: This study evaluated the postoperative quality of life (QoL) after various types of gastrectomy for gastric cancer. Materials and Methods: A multicenter prospective observational study was conducted in Korea using the Korean Quality of Life in Stomach Cancer Patients Study (KOQUSS)-40, a new QoL assessment tool focusing on postgastrectomy syndrome. Overall, 496 patients with gastric cancer were enrolled, and QoL was assessed at 5 time points: preoperatively and at 1, 3, 6, and 12 months after surgery. Results: Distal gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) showed significantly better outcomes than total gastrectomy (TG) and proximal gastrectomy (PG) with regard to total score, indigestion, and dysphagia. DG, PPG, and TG also showed significantly better outcomes than PG in terms of dumping syndrome and worry about cancer. Postoperative QoL did not differ significantly according to anastomosis type in DG, except for Billroth I anastomosis, which achieved better bowel habit change scores than the others. No domains differed significantly when comparing double tract reconstruction and esophagogastrostomy after PG. The total QoL score correlated significantly with postoperative body weight loss (more than 10%) and extent of resection (P<0.05 for both).Reflux as assessed by KOQUSS-40 did not correlate significantly with reflux observed on gastroscopy 1 year postoperatively (P=0.064). Conclusions Our prospective observation using KOQUSS-40 revealed that DG and PPG lead to better QoL than TG and PG. Further study is needed to compare postoperative QoL according to anastomosis type in DG and PG.

Purpose: Considering the high disease burden and unique features of Asian patients with breast cancer (BC), it is essential to have a comprehensive view of genetic characteristics in this population. An institutional targeted sequencing platform was developed through the Korea Research-Driven Hospitals project and was incorporated into clinical practice. This study explores the use of targeted next-generation sequencing (NGS) and its outcomes in patients with advanced/metastatic BC in the real world. Materials and Methods: We reviewed the results of NGS tests administered to BC patients using a customized sequencing platform—FiRST Cancer Panel (FCP)—over 7 years. We systematically described clinical translation of FCP for precise diagnostics, personalized therapeutic strategies, and unraveling disease pathogenesis. Results: NGS tests were conducted on 548 samples from 522 patients with BC. Ninety-seven point six percentage of tested samples harbored at least one pathogenic alteration. The common alterations included mutations in TP53 (56.2%), PIK3CA (31.2%), GATA3 (13.8%), BRCA2 (10.2%), and amplifications of CCND1 (10.8%), FGF19 (10.0%), and ERBB2 (9.5%). NGS analysis of ERBB2 amplification correlated well with human epidermal growth factor receptor 2 immunohistochemistry and in situ hybridization. RNA panel analyses found potentially actionable and prognostic fusion genes. FCP effectively screened for potentially germline pathogenic/likely pathogenic mutation. Ten point three percent of BC patients received matched therapy guided by NGS, resulting in a significant overall survival advantage (p=0.022), especially for metastatic BCs. Conclusion Clinical NGS provided multifaceted benefits, deepening our understanding of the disease, improving diagnostic precision, and paving the way for targeted therapies. The concrete advantages of FCP highlight the importance of multi-gene testing for BC, especially for metastatic conditions.

Purpose: This study evaluated the postoperative quality of life (QoL) after various types of gastrectomy for gastric cancer. Materials and Methods: A multicenter prospective observational study was conducted in Korea using the Korean Quality of Life in Stomach Cancer Patients Study (KOQUSS)-40, a new QoL assessment tool focusing on postgastrectomy syndrome. Overall, 496 patients with gastric cancer were enrolled, and QoL was assessed at 5 time points: preoperatively and at 1, 3, 6, and 12 months after surgery. Results: Distal gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) showed significantly better outcomes than total gastrectomy (TG) and proximal gastrectomy (PG) with regard to total score, indigestion, and dysphagia. DG, PPG, and TG also showed significantly better outcomes than PG in terms of dumping syndrome and worry about cancer. Postoperative QoL did not differ significantly according to anastomosis type in DG, except for Billroth I anastomosis, which achieved better bowel habit change scores than the others. No domains differed significantly when comparing double tract reconstruction and esophagogastrostomy after PG. The total QoL score correlated significantly with postoperative body weight loss (more than 10%) and extent of resection (P<0.05 for both).Reflux as assessed by KOQUSS-40 did not correlate significantly with reflux observed on gastroscopy 1 year postoperatively (P=0.064). Conclusions Our prospective observation using KOQUSS-40 revealed that DG and PPG lead to better QoL than TG and PG. Further study is needed to compare postoperative QoL according to anastomosis type in DG and PG.

This paper describes the design, development, and implementation of a ubiquitous portfolio (u-portfolio) system aimed at enhancing clinical clerkship education at Inje University College of Medicine from 2016 to 2020. This developmental research employed involved a literature review of 69 papers on electronic portfolios (1990–2013), and as well as a series of focus group interviews and surveys with key stakeholders during the iterative design, evaluation, and revision process. The literature analysis revealed three main purposes of e-portfolios (learning, assessment, and showcase) and nine key elements for a multi-purpose e-portfolio (e.g., quality of student reflection, postgraduate continuous learning, and timely and frequent feedback). The system evolved from paper-based portfolios to address the standardization of students’ clerkship experiences across five teaching hospitals, incorporating competency-based education and enabling efficient data management to promote student learning, assessment, and feedback. Key challenges in transitioning from paper to electronic portfolios included infrastructure issues, user adaptation, and assessment standardization. The resulting u-portfolio system, which allowed the seamless integration of mobile devices, emphasized five core functions: enhanced real-time feedback, transparent evaluation with rubrics, improved reflection quality, real-time assessment and tracking, and mapping between learning and competency achievements. Initially implemented in the internal medicine clerkship in 2016, the system was gradually expanded to all core clerkships by 2018. The success of this system led to its adoption by 19 medical schools through a consortium organized by the Korea Association of Medical Colleges, with 31 schools now collaborating to enhance clerkships through the u-portfolio system.

Purpose: Considering the high disease burden and unique features of Asian patients with breast cancer (BC), it is essential to have a comprehensive view of genetic characteristics in this population. An institutional targeted sequencing platform was developed through the Korea Research-Driven Hospitals project and was incorporated into clinical practice. This study explores the use of targeted next-generation sequencing (NGS) and its outcomes in patients with advanced/metastatic BC in the real world. Materials and Methods: We reviewed the results of NGS tests administered to BC patients using a customized sequencing platform—FiRST Cancer Panel (FCP)—over 7 years. We systematically described clinical translation of FCP for precise diagnostics, personalized therapeutic strategies, and unraveling disease pathogenesis. Results: NGS tests were conducted on 548 samples from 522 patients with BC. Ninety-seven point six percentage of tested samples harbored at least one pathogenic alteration. The common alterations included mutations in TP53 (56.2%), PIK3CA (31.2%), GATA3 (13.8%), BRCA2 (10.2%), and amplifications of CCND1 (10.8%), FGF19 (10.0%), and ERBB2 (9.5%). NGS analysis of ERBB2 amplification correlated well with human epidermal growth factor receptor 2 immunohistochemistry and in situ hybridization. RNA panel analyses found potentially actionable and prognostic fusion genes. FCP effectively screened for potentially germline pathogenic/likely pathogenic mutation. Ten point three percent of BC patients received matched therapy guided by NGS, resulting in a significant overall survival advantage (p=0.022), especially for metastatic BCs. Conclusion Clinical NGS provided multifaceted benefits, deepening our understanding of the disease, improving diagnostic precision, and paving the way for targeted therapies. The concrete advantages of FCP highlight the importance of multi-gene testing for BC, especially for metastatic conditions.

Purpose: This study evaluated the postoperative quality of life (QoL) after various types of gastrectomy for gastric cancer. Materials and Methods: A multicenter prospective observational study was conducted in Korea using the Korean Quality of Life in Stomach Cancer Patients Study (KOQUSS)-40, a new QoL assessment tool focusing on postgastrectomy syndrome. Overall, 496 patients with gastric cancer were enrolled, and QoL was assessed at 5 time points: preoperatively and at 1, 3, 6, and 12 months after surgery. Results: Distal gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) showed significantly better outcomes than total gastrectomy (TG) and proximal gastrectomy (PG) with regard to total score, indigestion, and dysphagia. DG, PPG, and TG also showed significantly better outcomes than PG in terms of dumping syndrome and worry about cancer. Postoperative QoL did not differ significantly according to anastomosis type in DG, except for Billroth I anastomosis, which achieved better bowel habit change scores than the others. No domains differed significantly when comparing double tract reconstruction and esophagogastrostomy after PG. The total QoL score correlated significantly with postoperative body weight loss (more than 10%) and extent of resection (P<0.05 for both).Reflux as assessed by KOQUSS-40 did not correlate significantly with reflux observed on gastroscopy 1 year postoperatively (P=0.064). Conclusions Our prospective observation using KOQUSS-40 revealed that DG and PPG lead to better QoL than TG and PG. Further study is needed to compare postoperative QoL according to anastomosis type in DG and PG.